BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32832663)

  • 21. Cancer regulatory variation.
    Hennessey RC; Brown KM
    Curr Opin Genet Dev; 2021 Feb; 66():41-49. PubMed ID: 33422949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identifying tumorigenic non-coding mutations through altered
    Cheng Z; Vermeulen M; Rollins-Green M; Babak T; DeVeale B
    STAR Protoc; 2021 Dec; 2(4):100934. PubMed ID: 34816127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Deep Learning Framework Identifies Pathogenic Noncoding Somatic Mutations from Personal Prostate Cancer Genomes.
    Wang C; Li J
    Cancer Res; 2020 Nov; 80(21):4644-4654. PubMed ID: 32907840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LARVA: an integrative framework for large-scale analysis of recurrent variants in noncoding annotations.
    Lochovsky L; Zhang J; Fu Y; Khurana E; Gerstein M
    Nucleic Acids Res; 2015 Sep; 43(17):8123-34. PubMed ID: 26304545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The search for cis-regulatory driver mutations in cancer genomes.
    Poulos RC; Sloane MA; Hesson LB; Wong JW
    Oncotarget; 2015 Oct; 6(32):32509-25. PubMed ID: 26356674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome-wide analysis of somatic noncoding mutation patterns in cancer.
    Dietlein F; Wang AB; Fagre C; Tang A; Besselink NJM; Cuppen E; Li C; Sunyaev SR; Neal JT; Van Allen EM
    Science; 2022 Apr; 376(6589):eabg5601. PubMed ID: 35389777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noncoding Variants Connect Enhancer Dysregulation with Nuclear Receptor Signaling in Hematopoietic Malignancies.
    Li K; Zhang Y; Liu X; Liu Y; Gu Z; Cao H; Dickerson KE; Chen M; Chen W; Shao Z; Ni M; Xu J
    Cancer Discov; 2020 May; 10(5):724-745. PubMed ID: 32188707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovering single nucleotide variants and indels from bulk and single-cell ATAC-seq.
    Massarat AR; Sen A; Jaureguy J; Tyndale ST; Fu Y; Erikson G; McVicker G
    Nucleic Acids Res; 2021 Aug; 49(14):7986-7994. PubMed ID: 34313779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Whole-genome sequencing of multiple myeloma reveals oncogenic pathways are targeted somatically through multiple mechanisms.
    Hoang PH; Dobbins SE; Cornish AJ; Chubb D; Law PJ; Kaiser M; Houlston RS
    Leukemia; 2018 Nov; 32(11):2459-2470. PubMed ID: 29654271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of noncoding mutations in blood cancers.
    Rahman S; Mansour MR
    Dis Model Mech; 2019 Nov; 12(11):. PubMed ID: 31771951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental approaches to evaluate the contributions of candidate cis-regulatory mutations to phenotypic evolution.
    Rebeiz M; Williams TM
    Methods Mol Biol; 2011; 772():351-75. PubMed ID: 22065449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Catalogue of Putative
    Basu S; Larsson E
    G3 (Bethesda); 2018 May; 8(6):2019-2025. PubMed ID: 29666194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of noncoding regulatory DNA in the human genome.
    Elkon R; Agami R
    Nat Biotechnol; 2017 Aug; 35(8):732-746. PubMed ID: 28787426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic analysis of noncoding somatic mutations and gene expression alterations across 14 tumor types.
    Fredriksson NJ; Ny L; Nilsson JA; Larsson E
    Nat Genet; 2014 Dec; 46(12):1258-63. PubMed ID: 25383969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Profile of Basal Cell Carcinoma Mutations and Copy Number Alterations - Focus on Gene-Associated Noncoding Variants.
    Nawrocka PM; Galka-Marciniak P; Urbanek-Trzeciak MO; M-Thirusenthilarasan I; Szostak N; Philips A; Susok L; Sand M; Kozlowski P
    Front Oncol; 2021; 11():752579. PubMed ID: 34900699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promoter capture Hi-C-based identification of recurrent noncoding mutations in colorectal cancer.
    Orlando G; Law PJ; Cornish AJ; Dobbins SE; Chubb D; Broderick P; Litchfield K; Hariri F; Pastinen T; Osborne CS; Taipale J; Houlston RS
    Nat Genet; 2018 Oct; 50(10):1375-1380. PubMed ID: 30224643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome-wide analysis of noncoding regulatory mutations in cancer.
    Weinhold N; Jacobsen A; Schultz N; Sander C; Lee W
    Nat Genet; 2014 Nov; 46(11):1160-5. PubMed ID: 25261935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional and genetic determinants of mutation rate variability in regulatory elements of cancer genomes.
    Lee CA; Abd-Rabbo D; Reimand J
    Genome Biol; 2021 May; 22(1):133. PubMed ID: 33941236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-accumulation of cis-regulatory and coding mutations during the pseudogenization of the Xenopus laevis homoeologs six6.L and six6.S.
    Ochi H; Kawaguchi A; Tanouchi M; Suzuki N; Kumada T; Iwata Y; Ogino H
    Dev Biol; 2017 Jul; 427(1):84-92. PubMed ID: 28501477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contrasting properties of gene-specific regulatory, coding, and copy number mutations in Saccharomyces cerevisiae: frequency, effects, and dominance.
    Gruber JD; Vogel K; Kalay G; Wittkopp PJ
    PLoS Genet; 2012 Feb; 8(2):e1002497. PubMed ID: 22346762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.